Skip to search formSkip to main contentSkip to account menu

SMYD3 gene

Known as: SET and MYND domain containing 3, KMT3E, SET AND MYND DOMAIN-CONTAINING PROTEIN 3 
This gene plays a regulatory role in histone methyltransferase activity and transcription.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
SMYD3 is a member of the SMYD lysine methylase family and plays an important role in the methylation of various histone and non… 
2016
2016
SMYD3 is a member of the SMYD family of lysine methyltransferases (KMTs). In humans, there are five SMYD members (SMYD1–5) that… 
2016
2016
SMYD3 plays a key role in cancer cell viability, adhesion, migration and invasion. SMYD3 promotes formation of inducible… 
2016
2016
The generation of cancer-specific gene expression patterns is attributed to aberrant activation of oncogenic transcription… 
Highly Cited
2015
Highly Cited
2015
Prostate cancer (PCa) is one of the most incident cancers worldwide but clinical and pathological parameters have limited ability… 
Highly Cited
2012
Highly Cited
2012
Smyd3 is a lysine methyltransferase implicated in chromatin and cancer regulation. Here we show that Smyd3 catalyzes histone H4… 
2012
2012
183 Background: SET and MYND Domain-Containing Protein 3 (SMYD3) is frequently overexpressed in hepatocellular carcinoma (HCC… 
Review
2011
Review
2011
The central dogma of molecular biology indicates that genetic information from DNA is transmitted to RNA, and then translated… 
2010
2010
SET and MYND domain-containing protein 3 (SMYD3) is a novel histone methyltransferase involved in human carcinogenesis. To…